Safety aspects of iron in food

Annals of Nutrition and Metabolism

Volumn 45, Issue 3, 2001, Pages 91-101

  Schümann, Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cancer; Cardiovascular risk; Iron; Toxicity; Upper level

Indexed keywords

HYDROXYL RADICAL; IRON; SUPEROXIDE;

ATHEROSCLEROSIS; CANCER GROWTH; CARDIOVASCULAR RISK; DIABETES MELLITUS; DNA DAMAGE; FOOD SAFETY; HEART FAILURE; HEART INFARCTION; HEMOCHROMATOSIS; HUMAN; IRON ABSORPTION; IRON DEFICIENCY; IRON INTAKE; IRON OVERLOAD; IRON STORAGE; LIVER FIBROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 0034939219     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046713     Document Type: Review

References (89)

1. Safety limits of nutrition
2. Improvement of nutrition in developing countries: Comparison of adding meat, soy protein, ascorbic acid, citric acid and ferrous sulfate on iron absorption from a simple Latin American meal
3. Estimation of available dietary iron
4. Effects of discontinuing coffee intake on iron status of iron-deficient Guatemalan toddlers: A randomized intervention study
5. Long-term developmental outcome of infants with iron-deficiency
6. Iron deficiency
7. Iron
8. Cloning and characterization of a mammalian proton-coupled metalion transporter
9. Iron regulatory protein as an endogenous sensor of iron in rat intetinal mucosa. Possible implications for the regulation of iron absorption
10. Gastrointestinal function, divalent metal transporter-1 expression and intestinal iron absorption
11. A novel duodenal iron-regulated transporter, IREG1, implicated in the baso-lateral transfer of iron to the circulation
12. An electron microscopic study of heme uptake by rat duodenum
13. Intestinal absorption of hemoglobin iron-heme clevage by mucosal heme oxygenase
14. Modulation of uptake of heme by rat small intestinal mucosa in iron deficiency
15. Iron absorption from the whole diet in men: How effective is the regulation of iron asborption
16. Absorption of non-haem iron from food during normal pregnancy
17. How little we know about the absorption of iron
18. Oral iron therapy - Factors affecting the absorption
19. Efficacy of weekly compared with daily iron supplementation
20. Primary iron overload
21. Competitive interaction of iron and zinc in the diet. Consequences for human nutrition
22. Regulation of the fate of mRNA: The control of cellular iron metabolism
23. Molecular control of vertebrate iron metabolism - mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress
24. Recent increases in numbers and risk of fatalities in young children ingesting iron preparations
25. Orale Eisenmedikation
26. Supplementary iron dose in pregnant anemia prophylaxis
27. Secondary hemochromatosis due to prolonged iron ingestion
28. Iron overload in Bantu subjects
29. Iron overload in Africa. Interaction between a gene and dietary iron control
30. Iron versus cholesterol - Perspectives on the iron and heart debate
31. Asbestos stimulates IL-8 production from human lung epithelial cells
32. Oxidative DNA damage mediated by copper (II), iron (II) and nickel (II) Fenton reactions: Evidence for site specific mechanisms in the formation of double-strand breaks, 8-hydroxyguanosine and putative in-strand cross-links
33. Iron, free radicals, and oxidative injury
34. Long-term induction of haem oxygenase-1 (HSP-32) in astrocytes and microglia following transient focal brain ischemia in the rat
35. Iron mobilization from ferritin by superoxide derived from stimulated PMN leukocytes
36. Patterns of metabolization of copper and iron following myocardial ischemia: Possible predictive criteria for tissue injury
37. Transition metal chelators reduce directly measured myocardial free radical production during reperfusion
38. The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction
39. Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts
40. Lipophilic siderophores of Mycobacterium tuberculosis prevent cardiac reperfusion injury
41. Desferoxamine prevents lipid peroxidation and attenuates reoxygenation injury in postischemic skeletal muscle
42. The effect of antioxidative combination therapy on posthypoxic-ischemic perfusion, metabolism, and electrical activity of the newborn brain
43. Desferal attenuates TNF release following hepatic ischemia/reperfusion
44. Ischemia/reperfusion injury is aggravated by an iron supplemented diet and is partly prevented by simultaneous antioxidant supplementation
45. The role of metals in ischemia/reperfusion injury of the liver
46. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men
47. Body iron stores and risk of coronary heart disease (letter)
48. Body iron stores and the risk of coronary heart disease
49. Iron stores are not associated with acute myocardial infarction
50. Low iron-binding capacity as a risk factor for myocardial infarction
51. Dietary iron intake and risk of coronary disease among men
52. Serum iron and fatal myocardial infarction
53. Iron and heart disease: The epidemiological data
54. Iron and the genetics of cardiovascular disease
55. Body iron stores and the risk of carotid atherosclerosis
56. Serum ferritin and risk of myocardial infarction in the elderly: The Rotterdam study
57. Association between body iron stores and the risk of acute myocardial infarction in men
58. Donation of blood as associated with reduced risk of myocardial infarction
59. Possible association of a reduction in cardiovascular events with blood donation
60. Relation of HFE gene mutations, high iron stores and early onset coronary artery disease
61. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis
62. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular mortality in women
63. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation
64. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material
65. Iron-deficient diet reduces atherosclerotic lesion in apoE-deficient mice
66. Lack of association between ferritin level and measures of LDL oxidation: The ARIC study
67. Body iron stores and presence of carotid atherosclerosis
68. Induction of rat renal adenocarcinoma by Fe-nitrilotriacetate (Fe-NTA)
69. Induction of mesothelioma by intraperitoneal injections of ferric succhrate in male Wistar rats
70. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen ferric nitrilotriacetate
71. Vitamin E inhibits apoptosis, DNA modification, and cancer induced by iron-mediated peroxidation in Wistar rat kidney
72. Oxidative DNA damage estimated by 8-hydroxy-deoxyguanosine excretion in humans: Influence of smoking, gender and body mass index
73. Asbestosis: Scientific developments and implications for public policy
74. Participation of iron and nitric oxide in the mutagenicity of asbestos in hpgrt-, gpt+ Chinese hamster V79 cells
75. Influence of iron on in vitro proliferation and lethality of L1210 cells
76. Effect of dietary iron deficiency or excess on the induction of mammary carcinogenesis by 1-methyl-1-nitrourea
77. Promotion of dimethylbenz(a)anthracene-initiated mammary carcinogenesis by iron in female Sprague-Dawley rats
78. Free radicals and the etiology of colon cancer
79. Body iron stores and the risk of cancer
80. Body iron stores and the risk of cancer (letter)
81. Moderate elevation of body iron level and increased risk of cancer occurrence and death
82. Dietary intrinsic phytate protects colon from lipid peroxidation in pigs with a moderately high iron intake
83. Body iron stores and risk of cancer
84. Role of deferoxamine in tumor therapy
85. The incidence of cancer among blood donors
86. Toxic metals: Interactions with essential metals
87. Regulation of iron metabolism in higher eukaryotes: Iron-sulfur centers as genetic switches